PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
Excellus BlueCross BlueShieldCommercial · Coverage · Digestive System (Gastroenterology) · NY · Gastroenterology, General Practice, Internal Medicine +1 moreHigh impact

Colorectal Cancer Screening and Surveillance 2.01.51

Effective date
Sep 17, 2026
Identified
Jun 20, 2026

Summary

Blood-based colorectal cancer screening tests changed from investigational to medically necessary when criteria are met, with a current effective date of September 17, 2026. Blood-based tests (for example Shield, CPT 0537U) are medically necessary every 3 years only when documentation confirms that the individual declines or has not completed one of the ACS-preferred screening tests and has been informed that blood-based screening has lower sensitivity for advanced precancerous lesions and early-stage colorectal cancer. The March 19, 2026 revision changed multi-target stool RNA testing (CPT 0421U) every 3 years from investigational to medically necessary.

Get alerts when payers change rules like this one

We check Excellus BlueCross BlueShield and other payers every day and email you when a change matches your specialty and state.

Get Excellus BlueCross BlueShield alertsPolicy Monitoring is free. No card required.

What to do

Action · 5 steps
01Already effective 2026-09-17: For blood-based colorectal cancer screening tests (for example CPT 0537U or HCPCS G0327), the policy is medically necessary every 3 years only when documentation confirms both that the individual declines or has not completed one of the ACS-preferred CRC screening tests, and that the individual has been informed that blood-based screening has lower sensitivity for detecting advanced precancerous lesions and early-stage colorectal cancer than the preferred tests.
02Keep this documentation with the claim for these services.
03Blood-based biomarker testing not approved by the FDA is considered investigational.
04For multi-target stool RNA testing (CPT 0421U), the policy is medically necessary every 3 years.
05Check current applicability of this policy before billing these services.

Codes mentioned

G0327

Original notice

Colorectal Cancer Screening and Surveillance 2.01.51
excellusbcbs.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account